STRS:TASEStrauss Group Ltd Analysis
Data as of 2026-03-17 - not real-time
$31.78
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
STRS is trading in a bullish technical environment – the 20‑day SMA sits above the 50‑day SMA, the RSI hovers around the 60‑point zone and the MACD line remains just above its signal, while volume is on an upward trend. The stock is perched near its recent resistance level and the DCF model points to a fair‑value target near $63, implying significant upside from the current price of $31.78.
However, the fundamentals are weak: revenue is down sharply, margins are negative, the company posted a loss per share and carries a high debt load relative to equity. The recent $60.8 million sale of the Kingwood Place asset adds cash but does not offset operating cash outflows. Combined with elevated 30‑day volatility (~32%) and a beta above 1.3, the stock presents a mixed picture of technical strength against a backdrop of financial distress.
However, the fundamentals are weak: revenue is down sharply, margins are negative, the company posted a loss per share and carries a high debt load relative to equity. The recent $60.8 million sale of the Kingwood Place asset adds cash but does not offset operating cash outflows. Combined with elevated 30‑day volatility (~32%) and a beta above 1.3, the stock presents a mixed picture of technical strength against a backdrop of financial distress.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Bullish short‑term technical indicators (SMA crossover, MACD, RSI)
- Proximity to resistance level limiting immediate upside
- Persistently negative earnings and high leverage
Medium Term
1–3 yearsPositive
Model confidence: 6/10
Key Factors
- DCF implied upside of roughly 100%
- Recent asset sale improving cash position
- Technical momentum supporting a gradual price climb
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Potential for turnaround if operating cash flow improves
- Undervalued relative to intrinsic value
- Long‑run real‑estate demand in Texas markets
Key Metrics & Analysis
Financial Health
Revenue Growth-44.10%
Profit Margin-25.38%
ROE-4.89%
ROA-1.93%
Debt/Equity65.98
P/B Ratio1.4
Op. Cash Flow$-27578000
Free Cash Flow$49.7M
Industry P/E32.8
Technical Analysis
TrendBullish
RSI60.8
Support$28.32
Resistance$32.93
MA 20$30.49
MA 50$28.73
MA 200$21.95
MACDBullish
VolumeIncreasing
Fear & Greed Index78.88
Valuation
Fair Value$63.08
GradeUndervalued
TypeValue
Risk Assessment
Beta1.31
Volatility31.84%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.